CannTrust Holdings (NYSE:CTST,TSX:TRST) is at risk of getting bumped off the New York Stock Exchange (NYSE) because of its too-low share price, the company said in a press release.

The embattled Ontario-based cannabis firm told investors on Tuesday (December 10) it had received a notice from the exchange stating that it no longer complies with the US$1 price-per-share threshold the NYSE requires over a consecutive 30 day period to remain in line with its listing standards.

As of 3:14 p.m. EST on Wednesday (December 11), CannTrust sat at US$0.81 on the NYSE. The last time shares were above the US$1 mark was on November 11, when they closed at US$1.04.

CannTrust said it now has six months to get its closing and average share price up to scratch for at least 30 days in a row, during which its common shares will continue to list on the NYSE.

The news comes just weeks after the Toronto Stock Exchange (TSX) said it would delist CannTrust’s TSX shares if did not receive certain financial documents by March 25, 2020, including restated interim financial statements for the first, second and third quarters of 2019.

“CannTrust anticipates filing those disclosures and meeting the TSX’s requirements before March 25, 2020. The company continues to make progress in working with its independent auditor in connection with preparing its financial statements and corresponding MD&A,” the firm said at the time.

The company has been under fire since July, when Health Canada flagged its cultivation facility in Pelham, Ontario, as non-compliant because the company was growing cannabis in unlicensed rooms and had used false walls to hide the illegal operations.

canntrust nyse stock chart

In the ensuing fallout, it was found that high-level executives, including former CEO Peter Aceto and former Chairman Eric Paul, knew about the illegal growing, which led to their departures from the firm.

In the months following the discovery, a second of CannTrust’s facilities was found to be non-compliant. Additionally, Ontario’s provincial cannabis retailer returned millions of dollars worth of CannTrust products and the company had its production license suspended by the federal regulator.

Since the initial non-compliance rating in July, CannTrust shares have plummeted almost 80 percent in New York and Toronto.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less